JP2022521491A5 - - Google Patents
Info
- Publication number
- JP2022521491A5 JP2022521491A5 JP2021547567A JP2021547567A JP2022521491A5 JP 2022521491 A5 JP2022521491 A5 JP 2022521491A5 JP 2021547567 A JP2021547567 A JP 2021547567A JP 2021547567 A JP2021547567 A JP 2021547567A JP 2022521491 A5 JP2022521491 A5 JP 2022521491A5
- Authority
- JP
- Japan
- Prior art keywords
- clause
- degrees
- pharmaceutically acceptable
- item
- crystalline form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962805175P | 2019-02-13 | 2019-02-13 | |
| US62/805,175 | 2019-02-13 | ||
| US201962805726P | 2019-02-14 | 2019-02-14 | |
| US62/805,726 | 2019-02-14 | ||
| PCT/US2020/018185 WO2020168125A1 (en) | 2019-02-13 | 2020-02-13 | Selective inhibitor of protein arginine methyltransferase 5 (prmt5) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521491A JP2022521491A (ja) | 2022-04-08 |
| JP2022521491A5 true JP2022521491A5 (https=) | 2023-02-21 |
Family
ID=69845552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547567A Pending JP2022521491A (ja) | 2019-02-13 | 2020-02-13 | タンパク質アルギニンメチルトランスフェラーゼ５（ｐｒｍｔ５）の選択的阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220160713A1 (https=) |
| EP (1) | EP3924360A1 (https=) |
| JP (1) | JP2022521491A (https=) |
| KR (1) | KR20210129051A (https=) |
| CN (1) | CN113811539A (https=) |
| AU (1) | AU2020223058A1 (https=) |
| BR (1) | BR112021015796A2 (https=) |
| CA (1) | CA3129612A1 (https=) |
| IL (1) | IL285536A (https=) |
| MX (1) | MX2021009796A (https=) |
| WO (1) | WO2020168125A1 (https=) |
| ZA (1) | ZA202105887B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11077101B1 (en) | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| WO2022026892A1 (en) | 2020-07-31 | 2022-02-03 | Tango Therapeutics, Inc. | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers |
| US20220251088A1 (en) * | 2020-12-10 | 2022-08-11 | Prelude Therapeutics, Incorporated | Processes for Making PRMT5 Inhibitors |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
| US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US5674278A (en) | 1989-08-24 | 1997-10-07 | Arterial Vascular Engineering, Inc. | Endovascular support device |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
| US20170198006A1 (en) * | 2014-06-25 | 2017-07-13 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| WO2016044576A1 (en) * | 2014-09-17 | 2016-03-24 | Epizyme, Inc. | Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor |
| MX2017010844A (es) * | 2015-02-24 | 2017-12-07 | Pfizer | Derivados de nucleosidos sustituidos utiles como agentes anticancerosos. |
| MA41828A (fr) * | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton |
| AR104326A1 (es) * | 2015-05-04 | 2017-07-12 | Lilly Co Eli | Compuestos nucleósidos 5-sustituidos |
| TWI870767B (zh) * | 2015-08-26 | 2025-01-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| EP3939986A1 (en) * | 2017-08-09 | 2022-01-19 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| US12552826B2 (en) * | 2018-08-07 | 2026-02-17 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
-
2020
- 2020-02-13 EP EP20712111.2A patent/EP3924360A1/en not_active Withdrawn
- 2020-02-13 BR BR112021015796-4A patent/BR112021015796A2/pt not_active Application Discontinuation
- 2020-02-13 KR KR1020217025767A patent/KR20210129051A/ko not_active Withdrawn
- 2020-02-13 AU AU2020223058A patent/AU2020223058A1/en not_active Abandoned
- 2020-02-13 CN CN202080014248.7A patent/CN113811539A/zh active Pending
- 2020-02-13 JP JP2021547567A patent/JP2022521491A/ja active Pending
- 2020-02-13 CA CA3129612A patent/CA3129612A1/en active Pending
- 2020-02-13 US US17/430,815 patent/US20220160713A1/en not_active Abandoned
- 2020-02-13 WO PCT/US2020/018185 patent/WO2020168125A1/en not_active Ceased
- 2020-02-13 MX MX2021009796A patent/MX2021009796A/es unknown
-
2021
- 2021-08-11 IL IL285536A patent/IL285536A/en unknown
- 2021-08-17 ZA ZA2021/05887A patent/ZA202105887B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521491A5 (https=) | ||
| US20240132474A1 (en) | Therapeutically active compounds and their methods of use | |
| US10434105B2 (en) | Therapeutically active compounds and their methods of use | |
| CN102612369B (zh) | 抗肿瘤效果增强剂 | |
| AU2016340087C1 (en) | Combination therapy for treating malignancies | |
| TW200924786A (en) | Certain compounds, compositions and methods | |
| JP2021514395A (ja) | 三置換ベンゾトリアゾール誘導体の使用方法 | |
| WO2015018060A1 (en) | Crystalline forms of therapeutically active compounds and use thereof | |
| NZ509405A (en) | Preparation of 1-(4-thio-thioarabinofuranosyl) cytosine derivatives and their use as anticancer agents and DNA replication inhibitors | |
| CA2652811A1 (en) | Potentiator of radiation therapy | |
| US20250368655A1 (en) | Small molecule inhibitors of bcr-abl | |
| CN116802175B (zh) | 谷氨酰胺类似物 | |
| US8420668B2 (en) | 1-(2H)-isoquinolone derivative | |
| US20160194281A1 (en) | Crystalline forms of silodosin | |
| CN107638424B (zh) | 一种egfr/her2受体酪氨酸激酶抑制剂在制备治疗癌症的药物中的用途 | |
| AU2024278807A1 (en) | Mitochondria specific transcription inhibitors | |
| TWI596098B (zh) | 埃克替尼馬來酸鹽的晶型及其用途 | |
| CN110709399A (zh) | 司来利塞的晶型 |